gismotherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Gismo Therapeutics, Inc. – Innovative Therapeutics for Alzheimer’s and Parkinson’s
Description Gismo Therapeutics Inc. is developing first-in-class oral therapeutics for the treatment of both Alzheimer’s Disease and Parkinson’s
Keywords Alzheimer, Parkinson, amyloid, GAG, Glycosaminoglycans , Endocytosis, Neuronal, cell, lysosome, Gismo, Therapeutics, biotech, fundamental, biochemical, Disease, pathogenesis, industry-leading, technology, neurodegenerative, first-in-class
Server Information
WebSite gismotherapeutics favicongismotherapeutics.com
Host IP 216.70.123.118
Location United States
Related Websites
Site Rank
More to Explore
gismotherapeutics.com Valuation
US$2,321,735
Last updated: 2023-05-18 06:44:45

gismotherapeutics.com has Semrush global rank of 4,558,792. gismotherapeutics.com has an estimated worth of US$ 2,321,735, based on its estimated Ads revenue. gismotherapeutics.com receives approximately 267,893 unique visitors each day. Its web server is located in United States, with IP address 216.70.123.118. According to SiteAdvisor, gismotherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,321,735
Daily Ads Revenue US$2,144
Monthly Ads Revenue US$64,295
Yearly Ads Revenue US$771,531
Daily Unique Visitors 17,860
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
gismotherapeutics.com. A 43200 IP: 216.70.123.118
gismotherapeutics.com. NS 21600 NS Record: ns2.mediatemple.net.
gismotherapeutics.com. NS 21600 NS Record: ns1.mediatemple.net.
gismotherapeutics.com. MX 21600 MX Record: 10 mail.gismotherapeutics.com.
gismotherapeutics.com. TXT 21600 TXT Record: v=spf1 a mx ip4:154.16.114.50 ip4:154.16.114.50 ip4:205.186.162.10 -all
HtmlToTextCheckTime:2023-05-18 06:44:45
Innovative Therapeutics for Alzheimer’s and Parkinson’s Disease Search for: Home Overview Team Science Investors News and Events Contact Us Search for: Home Overview Team Science Investors News and Events Contact Us Search for: Gismo Therapeutics Inc. is a biotech start-up company targeting fundamental biochemical processes that are at the root cause of Alzheimer’s and Parkinson’s Disease pathogenesis. The company has been awarded several prestigious research grants to further develop its industry-leading technology, GISMO , which is associated with a new hypothesis of the etiology of major neurodegenerative amyloid diseases. Gismo Therapeutics Inc. is developing first-in-class, disease-modifying oral therapeutics for the treatment of both Alzheimer’s Disease, and Parkinson’s Disease. News and Events Gismo Therapeutics Inc. Receives Two Grants to Develop Novel Therapeutics for Parkinson’s Disease October 12, 2017 Gismo Therapeutics Inc. Receives a Michael J. Fox Foundation for
HTTP Headers
HTTP/1.1 200 OK
Server: nginx/1.16.1
Date: Thu, 26 May 2022 20:16:11 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.3.11
X-Pingback: http://gismotherapeutics.com/xmlrpc.php
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Vary: User-Agent
gismotherapeutics.com Whois Information
Domain Name: GISMOTHERAPEUTICS.COM
Registry Domain ID: 1639772279_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enomdomains.com
Updated Date: 2021-12-14T02:19:50Z
Creation Date: 2011-02-11T23:00:55Z
Registry Expiry Date: 2025-02-11T23:00:55Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.MEDIATEMPLE.NET
Name Server: NS2.MEDIATEMPLE.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-26T21:22:12Z <<<

Copyright © 2022 WebZZ.US 0.0207